Abstract
Bone healing commences with an inflammatory reaction which initiates the regenerative healing process leading in the end to reconstitution of bone. An unbalanced immune reaction during this early bone healing phase is hypothesized to disturb the healing cascade in a way that delays bone healing and jeopardizes the successful healing outcome. The immune cell composition and expression pattern of angiogenic factors were investigated in a sheep bone osteotomy model and compared to a mechanically-induced impaired/delayed bone healing group. In the impaired/delayed healing group, significantly higher T cell percentages were present in the bone hematoma and the bone marrow adjacent to the osteotomy gap when compared to the normal healing group. This was mirrored in the higher cytotoxic T cell percentage detected under delayed bone healing conditions indicating longer pro-inflammatory processes. The highly activated periosteum adjourning the osteotomy gap showed lower expression of hematopoietic stem cell markers and angiogenic factors such as heme oxygenase and vascular endothelial growth factor. This indicates a deferred revascularization of the injured area due to ongoing pro-inflammatory processes in the delayed healing group. Results from this study suggest that there are unfavorable immune cells and factors participating in the initial healing phase. In conclusion, identifying beneficial aspects may lead to promising therapeutical approaches that might benefit further by eliminating the unfavorable factors.
Similar content being viewed by others
References
Andrew JG, Andrew SM, Freemont AJ, Marsh DR (1994) Inflammatory cells in normal human fracture healing. Acta Orthop Scand 65:462–466
Chaudhary SB, Liporace FA, Gandhi A, Donley BG, Pinzur MS, Lin SS (2008) Complications of ankle fracture in patients with diabetes. J Am Acad Orthop Surg 16:159–170
Collin-Osdoby P, Nickols GA, Osdoby P (1995) Bone cell function, regulation, and communication: a role for nitric oxide. J Cell Biochem 57:399–408
Colnot C, Huang S, Helms J (2006) Analyzing the cellular contribution of bone marrow to fracture healing using bone marrow transplantation in mice. Biochem Biophys Res Commun 350:557–561
Delavary BM, van der Veer WM, van Egmond M, Niessen FB, Beelen RH (2011) Macrophages in skin injury and repair. Immunobiology (in press)
Dulak J, Deshane J, Jozkowicz A, Agarwal A (2008) Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117:231–241
Einhorn TA, Lane JM (1998) Significant advances have been made in the way surgeons treat fractures. Clin Orthop Relat Res S2–S3
Einhorn TA, Majeska RJ, Rush EB, Levine PM, Horowitz MC (1995) The expression of cytokine activity by fracture callus. J Bone Miner Res 10:1272–1281
Epari DR, Schell H, Bail HJ, Duda GN (2006) Instability prolongs the chondral phase during bone healing in sheep. Bone 38:864–870
Epari DR, Kassi JP, Schell H, Duda GN (2007) Timely fracture-healing requires optimization of axial fixation stability. J Bone Joint Surg Am 89:1575–1585
Filbin MT (2006) How inflammation promotes regeneration. Nat Neurosci 9:715–717
Friedman AD (2009) Cell cycle and developmental control of hematopoiesis by Runx1. J Cell Physiol 219:520–524
Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Tsay A, Fitch J, Barnes GL, Graves DT, Einhorn TA (2003) Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res 18:1584–1592
Grochot-Przeczek A, Dulak J, Jozkowicz A (2011) Heme oxygenase-1 in neovascularisation: A diabetic perspective. Thromb Haemost 104 (in press)
Harper J, Klagsbrun M (1999) Cartilage to bone–angiogenesis leads the way. Nat Med 5:617–618
Hausman MR, Rinker BD (2004) Intractable wounds and infections: the role of impaired vascularity and advanced surgical methods for treatment. Am J Surg 187:44S–55S
Kasahara T, Imai S, Kojima H, Katagi M, Kimura H, Chan L, Matsusue Y (2011) Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture healing in diabetic mice. Bone (in press)
Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA (2001) Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16:1004–1014
Lacativa PG, Farias ML (2010) Osteoporosis and inflammation. Arq Bras Endocrinol Metabol 54:123–132
Lienau J, Schmidt-Bleek K, Peters A, Haschke F, Duda GN, Perka C, Bail HJ, Schutze N, Jakob F, Schell H (2009) Differential regulation of blood vessel formation between standard and delayed bone healing. J Orthop Res 27:1133–1140
Lienau J, Schmidt-Bleek K, Peters A, Weber H, Bail HJ, Duda GN, Perka C, Schell H (2010) Insight into the molecular pathophysiology of delayed bone healing in a sheep model. Tissue Eng Part A 16:191–199
Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549–555
Medina RJ, O'Neill CL, Sweeney M, Guduric-Fuchs J, Gardiner TA, Simpson DA, Stitt AW (2011) Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genomics 3:18
Mehta M, Strube P, Peters A, Perka C, Hutmacher D, Fratzl P, Duda GN (2011) Influences of age and mechanical stability on volume, microstructure, and mineralization of the fracture callus during bone healing: Is osteoclast activity the key to age-related impaired healing? Bone (in press)
Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958–969
Mountziaris PM, Mikos AG (2008) Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14:179–186
Murnaghan M, Li G, Marsh DR (2006) Nonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis? J Bone Joint Surg Am 88(Suppl 3):140–147
Opal SM (2000) Phylogenetic and functional relationships between coagulation and the innate immune response. Crit Care Med 28:S77–S80
Ozaki A, Tsunoda M, Kinoshita S, Saura R (2000) Role of fracture hematoma and periosteum during fracture healing in rats: interaction of fracture hematoma and the periosteum in the initial step of the healing process. J Orthop Sci 5:64–70
Roszer T (2011) Inflammation as death or life signal in diabetic fracture healing. Inflamm Res 60:3–10
Schell H, Thompson MS, Bail HJ, Hoffmann JE, Schill A, Duda GN, Lienau J (2008) Mechanical induction of critically delayed bone healing in sheep: radiological and biomechanical results. J Biomech 41:3066–3072
Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6:1191–1197
Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341:738–746
Suda T, Takakura N (2001) Role of hematopoietic stem cells in angiogenesis. Int J Hematol 74:266–271
**ng Z, Lu C, Hu D, Miclau T 3rd, Marcucio RS (2011) Rejuvenation of the inflammatory system stimulates fracture repair in aged mice. J Orthop Res (in press)
Zampetaki A, Kirton JP, Xu Q (2008) Vascular repair by endothelial progenitor cells. Cardiovasc Res 78:413–421
Acknowledgements
The authors would like to thank Dr. Bettina Willie for hel** in editing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by a grant from the German Research Foundation (DFG SFB 760). No benefit of any kind has been or will be received either directly or indirectly by the authors.
Rights and permissions
About this article
Cite this article
Schmidt-Bleek, K., Schell, H., Schulz, N. et al. Inflammatory phase of bone healing initiates the regenerative healing cascade. Cell Tissue Res 347, 567–573 (2012). https://doi.org/10.1007/s00441-011-1205-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-011-1205-7